Lymphocyte toxicity assay: A tool to assess trimethoprim-sulfamethoxazole hypersensitivity syndrome reactions in human immunodeficiency virus-infected individuals.

被引：0
|
作者：
Neuman, M [1 ]
Malkiewicz, I [1 ]
Phillips, E [1 ]
Rachlis, A [1 ]
Yeung, E [1 ]
Ong, D [1 ]
Shear, NH [1 ]
机构：
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1128
引用
收藏
页码：454A / 454A
页数：1
相关论文
共 50 条
  • [21] Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin
    Huan-Huan Wu
    Shuang-Yan Fang
    Yan-Xiao Chen
    Lan-Fang Feng
    World Journal of Clinical Cases, 2022, (09) : 2743 - 2750
  • [22] Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin
    Wu, Huan-Huan
    Fang, Shuang-Yan
    Chen, Yan-Xiao
    Feng, Lan-Fang
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (09) : 2743 - 2750
  • [23] The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus
    Lehmann, DF
    Liu, A
    Newman, N
    Blair, DC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (05) : 533 - 537
  • [24] A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystic carinii pneumonia in human immunodeficiency virus-infected persons
    El-Sadr, WM
    Luskin-Hawk, R
    Yurik, TM
    Walker, J
    Abrams, D
    John, SL
    Sherer, R
    Crane, L
    Labriola, A
    Caras, S
    Pulling, C
    Hafner, R
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) : 775 - 783
  • [25] Trimethoprim-Sulfamethoxazole Exposure Alters Ex Vivo Function of B Lymphocytes Isolated from Human Immunodeficiency Virus-Infected Patients Receiving Zidovudine
    Venugopalan, Veena
    Thornton, Alice C.
    Steinke, Douglass T.
    Rapp, Robert P.
    Romanelli, Frank
    Feola, David J.
    PHARMACOTHERAPY, 2009, 29 (04): : 373 - 382
  • [26] Identification of human immunodeficiency virus-infected individuals by delayed type hypersensitivity skin testing
    Metersky, ML
    Yang, P
    Nielsen, HS
    Catanzaro, A
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1998, 28 (05) : 272 - 279
  • [27] Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus
    Smith, CL
    Brown, I
    Torraca, BM
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (06) : 1477 - 1478
  • [28] Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole
    Beumont, MG
    Graziani, A
    Ubel, PA
    MacGregor, RR
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06) : 611 - 616
  • [29] USE OF LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE THRICE WEEKLY FOR PRIMARY AND SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    STEIN, DS
    STEVENS, RC
    TERRY, D
    LAIZURE, SC
    PALTE, S
    LANCASTER, DJ
    WEEMS, JJ
    WILLIAMS, CL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1705 - 1709
  • [30] A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus
    Caumes, E
    Guermonprez, G
    Winter, C
    Katlama, C
    Bricaire, F
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) : 1313 - 1314
12345